Abstract
Luteal phase Gonadotropin-releasing hormone (GnRH) down regulation is commonly used to prevent ovulation during controlled hyperstimulation. Extended release GnRH agonists can be used to reduce the number of daily injections in oocyte donors. We examined parameters of in vitro fertilization (IVF) cycles to determine whether depot leuprolide acetate (LA) is an acceptable alternative to daily subcutaneous (SQ) LA.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
